Martín RJ, Ramírez CAL, Redondo SF, Ronzon RAA, Tirado GBP

Language: Spanish
References: 14
Page: 159-165
PDF size: 473.53 Kb.

ABSTRACT

Objective: To show the histopathological correlation of non palpable injuries, and being suspicious of malignity and shown through mastography in the Hospital General de México, through percutaneous biopsies with 11G cutting thick needle and vacuum through sterotaxy (BACVE).
Material and methods: 80 BACVE of patients, shown through mastography, age ranging between 32 and 71 years old, from January 1^st, 2005, to December 31^st, 2007, using a GE analogical mastographer with digital vertical stereotaxy and with a Mammotome Biopsy equipment. Findings were micro-calcifications, nodules, asymmetrical densities and destruction distortion; and being classified in the categories BI-RADS 3, 4 and 5.
Results: 80 patients were studied, findings were 38 micro-calcifications (47.5%), 37 nodules (46.25%) and an asymmetrical density (1.25%). 66 injuries were benign (82.5%) and 14 malign (17.5%), the age group more affected was younger than 39 years old. The ratio between benignity vs. malignity was of 5.7:1. The more frequent malign subtype was the canalicular carcinoma in situ in seven patients (50%). The most common benign lesion was a fibrocystic condition, found in 39 patients (48.75%).
Conclusions: The BACVE is less expensive and invasive, besides if the diagnosis is a carcinoma, tumor markers may be obtained as well as hormonal receptors that provide a predictive value and a prognosis to plan a specific treatment.

REFERENCES

1. Aguilar RZ. Microcalcificaciones mamarias: frecuencia, manejo y evolución en el consultorio de mastología del servicio de cirugía general –HCIPS. Mem Inst Investig Cienc Salud 2007; 5(1): 4-8.

2. Hall FM, Storella JM, Silverstone DZ, et al. Nonpalpable breast lesions: Recommendations for biopsy based on suspicion of carcinoma at mammography. Radiology 1988; 167: 353-8.

3. Yankaskas BC, Knelson MH, Abernethy ML, et al. Needle localization biopsy of occult lesion of the breast. Experience in 199 cases. Invest Radiol 1988; 23: 729-33.

4. Feig SA. Decreased breast cancer mortality through mammographic screening: Results of clinical trials. Radiology 1998; 167: 659-65.

5. Tabar L, Fagerberg G, Duffy S, et al. Update of the Swedish two country program of mammographic screening for breast cancer. Radiol Clin Notrh Am 1992; 30: 187-210.

6. George H. Radiopathological correlations of occult tumor of the breast. Radio-Graphics 1982; 2(3) 409-11.

7. Gómez A, Hoffman H, Viteri Y, De Lima M, Rennola A, Parodi M, et al. Manejo de las lesiones no palpables de la glándula mamaria correlación radiológica quirúrgica y anatomopatológica. Resultados de un equipo multidisciplinario. Rev Venz Onco 2000; 12(2): 81-7.

8. Jackman RJ, Marzoni FA, Finkelstein S, et al. Benefits of diagnosing nonpalpable breast cancer with stereotactic large-core needle biopsy: Lower costs and fewer operations. Radiology 1996; 201: 311.

9. Burbank F. Stereotactic breast biopsy: Comparison of 14 and 11 gauge Mammotome probe performance and complication rates. Am Surg 1997; 63: 988-95.

10. Comstock CE. Capítulo 12. Biopsia guiada por estereotaxis con aguja gruesa. En: Venta L (ed.). Mamografía Intervención e Imagen. Lippincott Williams and Wilkins; 2000, p. 219-33.

11. Shapiro S, Venet W, Strax P, et al. Periodic Screening for Breast Cancer: The Health Insurance Plan Project and its Sequel, 1968-86. Baltimore: Johns Hopkins University Press; 1988.

12. Helvie MA, Ikeda DM, Adler DD. Localization and needle aspiration of breast lesions: complications in 370 cases. AJR 1991; 157(4): 711-4.

13. Mettlin C. Global Breast cancer Mortality Statistics. CA Cancer J Clin 1999; 49: 138-44.

14. Liberman L, Hann LE, Dershaw DD, et al. Mammographic Findings after Stereotactic 14-gauge Vacuum Bipsy. Radiology 1997; 203: 343-7.